Prentice Wealth Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-300
| Closed | -$1K | – | 177 |
|
2022
Q2 | $1K | Buy |
+300
| New | +$1K | ﹤0.01% | 136 |
|
2021
Q4 | – | Sell |
-300
| Closed | -$2K | – | 299 |
|
2021
Q3 | $2K | Sell |
300
-150
| -33% | -$1K | ﹤0.01% | 302 |
|
2021
Q2 | $3K | Hold |
450
| – | – | ﹤0.01% | 288 |
|
2021
Q1 | $3K | Buy |
+450
| New | +$3K | ﹤0.01% | 289 |
|